Zaxol 100mg Infusion

Introduction

Zaxol is a medication that contains the active ingredient Paclitaxel. It is available in the form of an infusion and is used in the treatment of certain types of cancers.

Uses

Zaxol is primarily prescribed for the treatment of breast cancer, ovarian cancer, and non-small cell lung cancer. It is also used in combination with other medications for the treatment of AIDS-related Kaposi’s sarcoma.

Dosage and Administration

The dosage of Zaxol depends on several factors, including the type and stage of cancer being treated, as well as the patient’s overall health. It is administered intravenously by a healthcare professional in a hospital or clinic setting. The infusion is typically given over a period of several hours, and the frequency and duration of treatment may vary.

Mechanism of Action

Paclitaxel, the active ingredient in Zaxol, works by inhibiting the growth of cancer cells. It does this by interfering with the normal function of microtubules, which are essential for cell division. By disrupting the microtubules, Paclitaxel prevents cancer cells from dividing and multiplying, ultimately leading to their death.

Side Effects

Common side effects may include nausea, vomiting, hair loss, fatigue, and decreased blood cell counts. Note that not all patients will experience these side effects, and their severity can vary.

Serious side effects, although less common, may include severe allergic reactions, heart problems, nerve damage, and infections. If any of these serious side effects occur, seek immediate medical attention.

Drug Interactions

Before starting treatment with Zaxol. Inform your healthcare provider about all other medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some medications may interact with Paclitaxel, potentially affecting its effectiveness or increasing the risk of side effects. Common drug interactions include certain antibiotics, antifungal medications, and certain heart medications. Follow your healthcare provider’s instructions and report any new medications you start taking while on Zaxol.

Precautions

There are certain precautions to keep in mind when using Zaxol. Inform your healthcare provider if you have any allergies, especially to medications containing Paclitaxel or other ingredients in Zaxol. Additionally, let your healthcare provider know if you have any other medical conditions, such as liver or kidney problems, as this may affect the dosage and administration of the medication.

Zaxol should not be used during pregnancy or while breastfeeding, as it may harm the developing fetus or nursing infant. Use effective contraception during treatment and for a certain period after the last dose, as advised by your healthcare provider.

Storage

Patient Tips

• Follow your healthcare provider’s instructions regarding the dosage and administration of Zaxol.
• If you experience any side effects or have concerns, be sure to communicate with your healthcare provider. They can provide guidance and support.
• attend all scheduled appointments for Zaxol treatment and to inform your healthcare provider of any changes in your condition.
• Take precautions to avoid infections, as your immune system may be weakened during treatment. Wash your hands regularly and avoid close contact with individuals who are sick.
• Consider asking your healthcare provider about support services or resources that may be available to you during your treatment journey.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Abraxane 5 mg/ml powder for dispersion for infusion (Health Professionals SmPC) Available at:
• Paclitaxel (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• paclitaxel protein-bound 100 mg intravenous suspension antineoplastic – taxanes (RX) [Accessed 2 Jun. 2024] (online) Available at:
• Paclitaxel (with albumin) Injection [Accessed 1 Jun. 2024] (online) Available at:
• Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019 Jun 13;24:40. doi: 10.1186/s11658-019-0164-y. eCollection 2019. [Accessed 25 Jun. 2024] Available at: